Condition: Infertility · Implantation Rate · Clinical Pregnancy Rate · Sponsor: ART Fertility Clinics LLC
It has been proposed that enriching transfer media with hyaluronan (EmbryoGlue medium) improves pregnancy outcomes compared with media containing lower concentrations of this molecule. However, none of previous studies included preimplantation genetic testing for aneuploidy (PGT-A) embryos. In order to investigate the impact of this hyaluronan-enriched on pregnancy outcomes, it is essential to evaluate its efficacy on euploid-only embryo transfers. The aim of the present study is to evaluate whether a short period of exposure of euploid blastocysts to EmbryoGlue prior to and during transfer positively impact on pregnancy outcomes of frozen embryo transfer (FET) cycles.
This description comes directly from the study's public registry record.
Daniela Nogueira · +971504374961 · daniela.nogueira@artfertilityclinics.com
Jonalyn DV Edades, Nursing · +97152640866 · jonalyn.edades@artfertilityclinics.com
Always discuss trial participation with your own doctor first.
| ART Fertility Clinics LLC | Abu Dhabi, Abu Dhabi Emirate, United Arab Emirates | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06165367